BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18628320)

  • 1. Dosimetric comparison of 106Ru and 125I plaques for treatment of shallow (Wilkinson DA; Kolar M; Fleming PA; Singh AD
    Br J Radiol; 2008 Oct; 81(970):784-9. PubMed ID: 18628320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma.
    Wilson MW; Hungerford JL
    Ophthalmology; 1999 Aug; 106(8):1579-87. PubMed ID: 10442907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
    Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
    Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of choroidal melanomas treated with eye physics: a 20-year review.
    Berry JL; Dandapani SV; Stevanovic M; Lee TC; Astrahan M; Murphree AL; Kim JW
    JAMA Ophthalmol; 2013 Nov; 131(11):1435-42. PubMed ID: 24008431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retrospective analysis of ruthenium-106 brachytherapy for small and medium-sized malignant melanoma of the posterior choroid].
    Stoffelns BM; Kutzner J; Jochem T
    Klin Monbl Augenheilkd; 2002 Apr; 219(4):216-20. PubMed ID: 12022004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric and late radiation toxicity comparison between iodine-125 brachytherapy and stereotactic radiation therapy for juxtapapillary choroidal melanoma.
    Krema H; Heydarian M; Beiki-Ardakani A; Weisbrod D; Xu W; Laperriere NJ; Sahgal A
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):510-5. PubMed ID: 23507292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiation optic neuropathy after the brachytherapy of the uveal melanoma].
    Szuścik I; Romanowska-Dixon B; Markiewicz A; Pogrzebielski A; Jakubowska B
    Klin Oczna; 2006; 108(7-9):278-80. PubMed ID: 17290823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of choroidal melanomas less than 10 mm in largest basal diameter with a 10-mm ruthenium plaque.
    Salkola S; Heikkonen J; Eskelin S; Kivelä T
    Retina; 2014 Oct; 34(10):2110-20. PubMed ID: 24978431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttreatment visual acuity in patients treated with episcleral plaque therapy for choroidal melanomas: dose and dose rate effects.
    Jones R; Gore E; Mieler W; Murray K; Gillin M; Albano K; Erickson B
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):989-95. PubMed ID: 11958893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of plaque brachytherapy dose and dose rate on risk for disease-related mortality in 1238 patients with choroidal melanoma.
    Filì M; Trocme E; Herrspiegel C; Seregard S; Stålhammar G
    Br J Ophthalmol; 2021 Jan; 105(1):57-62. PubMed ID: 32430342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas.
    Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):392-400. PubMed ID: 15990248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Zealand experience of I125 brachytherapy for choroidal melanoma.
    Stack R; Elder M; Abdelaal A; Hidajat R; Clemett R
    Clin Exp Ophthalmol; 2005 Oct; 33(5):490-4. PubMed ID: 16181274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study.
    Saconn PA; Gee CJ; Greven CM; McCoy TP; Ekstrand KE; Greven KM
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):844-8. PubMed ID: 20171804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
    Puusaari I; Heikkonen J; Kivelä T
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric benefit of a new ophthalmic radiation plaque.
    Marwaha G; Wilkinson A; Bena J; Macklis R; Singh AD
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1226-30. PubMed ID: 22658440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plaque radiotherapy for juxtapapillary choroidal melanoma overhanging the optic disc in 141 consecutive patients.
    Sagoo MS; Shields CL; Mashayekhi A; Freire J; Emrich J; Reiff J; Komarnicky L; Shields JA
    Arch Ophthalmol; 2008 Nov; 126(11):1515-22. PubMed ID: 19001218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric and radiobiologic comparison of
    Gorovets D; Gagne NL; Melhus CS
    Brachytherapy; 2017; 16(2):433-443. PubMed ID: 28161431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does escalation of the apical dose change treatment outcome in beta-radiation of posterior choroidal melanomas with 106Ru plaques?
    Hermann RM; Pradier O; Lauritzen K; Ott M; Schmidberger H; Hess CF
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1360-6. PubMed ID: 11955750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of the poster "Dosimetric comparison of gamma knife radiosurgery vs. 125I plaque brachytherapy in a cohort of choroidal melanomas".
    Odell KR
    Med Dosim; 2009; 34(2):107-9. PubMed ID: 19410138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 106Ru/106Rh plaque and proton radiotherapy for ocular melanoma: a comparative dosimetric study.
    Mourtada F; Koch N; Newhauser W
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):454-60. PubMed ID: 16604677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.